NasdaqGS - Nasdaq Real Time Price USD

Alignment Healthcare, Inc. (ALHC)

14.85 -3.76 (-20.20%)
At close: July 31 at 4:00:01 PM EDT
15.09 +0.24 (+1.62%)
After hours: July 31 at 7:58:22 PM EDT
Trade ALHC on Coinbase
ALHC Q2 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for ALHC
  • Previous Close 18.61
  • Open 15.50
  • Bid 11.65 x 200
  • Ask 19.02 x 200
  • Day's Range 13.14 - 16.49
  • 52 Week Range 12.97 - 25.12
  • Volume 17,424,933
  • Avg. Volume 6,078,656
  • Market Cap (intraday) 3.08B
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) 78.16
  • EPS (TTM) 0.19
  • Earnings Date (est.) Oct 29, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 24.92

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

www.alignmenthealth.com

1,849

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 7/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALHC
24.81%
S&P 500 (^GSPC)
9.41%

1-Year Return

ALHC
7.76%
S&P 500 (^GSPC)
18.15%

3-Year Return

ALHC
139.13%
S&P 500 (^GSPC)
63.21%

5-Year Return

ALHC
28.71%
S&P 500 (^GSPC)
70.40%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.34B
Earnings 36.56M

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
 

Analyst Insights

View More

Analyst Price Targets

16.00
24.92 Average
14.85 Current
30.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 5/26/2026
Analyst Barclays
Rating Action Maintains
Rating Equal-Weight
Price Action Lowers
Price Target 19 -> 16
 

Statistics

View More

Valuation Measures

Annual
As of 3/16/2026
  • Market Cap

    3.08B

  • Enterprise Value

    2.71B

  • Trailing P/E

    78.11

  • Forward P/E

    204.08

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.66

  • Price/Book (mrq)

    11.61

  • Enterprise Value/Revenue

    0.59

  • Enterprise Value/EBITDA

    31.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.89%

  • Return on Assets (ttm)

    3.07%

  • Return on Equity (ttm)

    20.04%

  • Revenue (ttm)

    4.58B

  • Net Income Avi to Common (ttm)

    40.7M

  • Diluted EPS (ttm)

    0.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    701.71M

  • Total Debt/Equity (mrq)

    124.65%

  • Levered Free Cash Flow (ttm)

    188.58M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

14.85 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

Research Reports

View More
  • Lowering target price to $18.00

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $18.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Raising target price to $23.00

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $23.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • Lowering target price to $22.00

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • What does Argus have to say about ALHC?

    Alignment Healthcare Inc has an Investment Rating of HOLD; a target price of $25.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     

People Also Watch